Pathology



US FDA Clears Estrogen Receptor Image Analysis and Digital Read Application for Breast Cancer
Software for estrogen receptor-analysis now completes the only FDA-cleared testing package providing five key breast cancer biomarkers with their corresponding image analysis algorithms and digital read applications. More...24 Dec 2013


In Other News
Dual Assay Test Detects Colorectal Cancer
BRCA-Negative Results May Not Reduce Cancer Risk
Cervical Cancer Screening Overused in Some Groups
Urine Biomarker Helps Detect Aggressive Bladder Cancer
Early Access Offered to New, Streamlined Interpretation of Patient Sequencing Data
New Diagnostic Tool: Identification of Cancer Cells by Deformability Cytometry
Elevated Levels of Vitamin B12 May Indicate Cancer Risk
Tissue Samples Marked with Unprecedented Accuracy
Blood Test Differentiates Benign Lung Nodules from Lung Cancer
Simple Blood Test Diagnoses Specific Lung Cancer Subtypes
New Tissue Preparation Solution Enables Increased Efficiency for Molecular Pathology Laboratories
Genetic Cause of Warburg Micro Syndrome Identified
Blood Test Could Replace Mammography and Clinical Examinations for Diagnosis of Breast Cancer
New Molecular Standards Facilitate Assay Development, Validation, and Monitoring
Diagnostic Blood Test Determines Irritable Bowel Syndrome
Novel Biomarker Predicts Steatohepatitis Severity
Blood Test Reveals Skin Cancer Spread
Blood Levels of Genetic Material Predict Thyroid Cancer Recurrence
Assay for Risk of Kidney-Allograft Rejection Receives CE Marking Approval
Biomarkers Could Lead to Early Diagnosis of Colorectal Cancer
Microfluidic Probe Evaluated as a Device for Diagnosing Cancer
Genetic Errors Identified in 12 Major Cancer Types
Rare Bone Tumors Distinguished by Specific Histone Mutations
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.